<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>In the media | ANTICOV Trial</title>
	<atom:link href="https://anticov.org/category/in-the-media/feed/" rel="self" type="application/rss+xml" />
	<link>https://anticov.org/category/in-the-media/</link>
	<description>Platform trial to find early treatment options for COVID-19 in low-resource settings</description>
	<lastBuildDate>Wed, 08 Mar 2023 13:48:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.1</generator>

<image>
	<url>https://anticov.org/wp-content/uploads/2021/07/cropped-favicon-32x32.png</url>
	<title>In the media | ANTICOV Trial</title>
	<link>https://anticov.org/category/in-the-media/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Devex &#8211; “Pan-African platform aims to hasten clinical trials”</title>
		<link>https://anticov.org/in-the-media/2023/devex-pan-african-platform-aims-to-hasten-clinical-trials/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Tue, 07 Mar 2023 13:47:07 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2443</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2023/devex-pan-african-platform-aims-to-hasten-clinical-trials/">Devex &#8211; “Pan-African platform aims to hasten clinical trials”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.devex.com/news/pan-african-platform-aims-to-hasten-clinical-trials-105020" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2023/devex-pan-african-platform-aims-to-hasten-clinical-trials/">Devex &#8211; “Pan-African platform aims to hasten clinical trials”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Nature &#8211; “The hunt for drugs for mild COVID: scientists seek to treat those at lower risk”</title>
		<link>https://anticov.org/in-the-media/2022/nature-the-hunt-for-drugs-for-mild-covid-scientists-seek-to-treat-those-at-lower-risk/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Mon, 18 Jul 2022 08:36:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2397</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nature-the-hunt-for-drugs-for-mild-covid-scientists-seek-to-treat-those-at-lower-risk/">Nature &#8211; “The hunt for drugs for mild COVID: scientists seek to treat those at lower risk”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.nature.com/articles/d41586-022-01923-5" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nature-the-hunt-for-drugs-for-mild-covid-scientists-seek-to-treat-those-at-lower-risk/">Nature &#8211; “The hunt for drugs for mild COVID: scientists seek to treat those at lower risk”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Salon- “Rollout of new effective COVID pill mirrors the &#8220;injustice of vaccine apartheid&#8221; in poor countries”</title>
		<link>https://anticov.org/in-the-media/2022/salon-rollout-of-new-effective-covid-pill-mirrors-the-injustice-of-vaccine-apartheid-in-poor-countries/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Tue, 26 Apr 2022 08:18:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2326</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/salon-rollout-of-new-effective-covid-pill-mirrors-the-injustice-of-vaccine-apartheid-in-poor-countries/">Salon- “Rollout of new effective COVID pill mirrors the &#8220;injustice of vaccine apartheid&#8221; in poor countries”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.salon.com/2022/04/26/rollout-of-new-effective-pill-mirrors-the-injustice-of-vaccine-apartheid-in-poor-countries_partner/" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/salon-rollout-of-new-effective-covid-pill-mirrors-the-injustice-of-vaccine-apartheid-in-poor-countries/">Salon- “Rollout of new effective COVID pill mirrors the &#8220;injustice of vaccine apartheid&#8221; in poor countries”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Libération &#8211; “Nouveaux traitements contre le Covid: «Il faut rester vigilants et être prêts, ce qui n’est pas encore le cas»”</title>
		<link>https://anticov.org/in-the-media/2022/liberation-nouveaux-traitements-contre-le-covid-il-faut-rester-vigilants-et-etre-prets-ce-qui-nest-pas-encore-le-cas/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Mon, 11 Apr 2022 07:13:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2321</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/liberation-nouveaux-traitements-contre-le-covid-il-faut-rester-vigilants-et-etre-prets-ce-qui-nest-pas-encore-le-cas/">Libération &#8211; “Nouveaux traitements contre le Covid: «Il faut rester vigilants et être prêts, ce qui n’est pas encore le cas»”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.liberation.fr/societe/sante/nouveaux-traitements-contre-le-covid-il-faut-rester-vigilants-et-etre-prets-ce-qui-nest-pas-encore-le-cas-20220411_BCO4YWI4LBCHFD7QWEQEL23JSA/" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/liberation-nouveaux-traitements-contre-le-covid-il-faut-rester-vigilants-et-etre-prets-ce-qui-nest-pas-encore-le-cas/">Libération &#8211; “Nouveaux traitements contre le Covid: «Il faut rester vigilants et être prêts, ce qui n’est pas encore le cas»”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Nature- “African clinical trial denied access to key COVID drug Paxlovid”</title>
		<link>https://anticov.org/in-the-media/2022/nature-african-clinical-trial-denied-access-to-key-covid-drug-paxlovid/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Mon, 04 Apr 2022 08:19:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2323</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nature-african-clinical-trial-denied-access-to-key-covid-drug-paxlovid/">Nature- “African clinical trial denied access to key COVID drug Paxlovid”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.nature.com/articles/d41586-022-00919-5" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nature-african-clinical-trial-denied-access-to-key-covid-drug-paxlovid/">Nature- “African clinical trial denied access to key COVID drug Paxlovid”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Agence Congolaise de Presse &#8211; “Covid-19 : Pfizer bloque les recherches sur l’utilisation de son nouveau médicament antiviral dans les pays à revenu faible”</title>
		<link>https://anticov.org/in-the-media/2022/agence-congolaise-de-presse-covid-19-pfizer-bloque-les-recherches-sur-lutilisation-de-son-nouveau-medicament-antiviral-dans-les-pays-a-revenu-faible/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Thu, 17 Mar 2022 08:53:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2309</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/agence-congolaise-de-presse-covid-19-pfizer-bloque-les-recherches-sur-lutilisation-de-son-nouveau-medicament-antiviral-dans-les-pays-a-revenu-faible/">Agence Congolaise de Presse &#8211; “Covid-19 : Pfizer bloque les recherches sur l’utilisation de son nouveau médicament antiviral dans les pays à revenu faible”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://acpcongo.com/index.php/2022/03/17/covid-19-pfizer-bloque-les-recherches-sur-lutilisation-de-son-nouveau-medicament-antiviral-dans-les-pays-a-revenu-faible/" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/agence-congolaise-de-presse-covid-19-pfizer-bloque-les-recherches-sur-lutilisation-de-son-nouveau-medicament-antiviral-dans-les-pays-a-revenu-faible/">Agence Congolaise de Presse &#8211; “Covid-19 : Pfizer bloque les recherches sur l’utilisation de son nouveau médicament antiviral dans les pays à revenu faible”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>British Medical Journal &#8211; “Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries”</title>
		<link>https://anticov.org/in-the-media/2022/bmj-covid-19-campaigners-accuse-pfizer-of-blocking-access-to-antiviral-for-trials-in-poorer-countries/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Thu, 17 Mar 2022 08:52:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2307</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/bmj-covid-19-campaigners-accuse-pfizer-of-blocking-access-to-antiviral-for-trials-in-poorer-countries/">British Medical Journal &#8211; “Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.bmj.com/content/376/bmj.o721" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/bmj-covid-19-campaigners-accuse-pfizer-of-blocking-access-to-antiviral-for-trials-in-poorer-countries/">British Medical Journal &#8211; “Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Actualité CD &#8211; “Covid-19 en Afrique : pour l’étude Anticov, la nouvelle association thérapeutique ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée”</title>
		<link>https://anticov.org/in-the-media/2022/actualite-cd-covid-19-en-afrique-pour-letude-anticov-la-nouvelle-association-therapeutique-ne-reduit-pas-le-risque-dhospitalisation-chez-les-patients-atteints-d/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Thu, 17 Mar 2022 08:49:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2305</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/actualite-cd-covid-19-en-afrique-pour-letude-anticov-la-nouvelle-association-therapeutique-ne-reduit-pas-le-risque-dhospitalisation-chez-les-patients-atteints-d/">Actualité CD &#8211; “Covid-19 en Afrique : pour l’étude Anticov, la nouvelle association thérapeutique ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://actualite.cd/2022/03/17/covid-19-en-afrique-pour-letude-anticov-la-nouvelle-association-therapeutique-ne-reduit" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/actualite-cd-covid-19-en-afrique-pour-letude-anticov-la-nouvelle-association-therapeutique-ne-reduit-pas-le-risque-dhospitalisation-chez-les-patients-atteints-d/">Actualité CD &#8211; “Covid-19 en Afrique : pour l’étude Anticov, la nouvelle association thérapeutique ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Nation Africa &#8211; “Researchers fault Pfizer for non-cooperation on its Covid pill”</title>
		<link>https://anticov.org/in-the-media/2022/nation-africa-researchers-fault-pfizer-for-non-cooperation-on-its-covid-pill/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Wed, 16 Mar 2022 08:55:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2311</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nation-africa-researchers-fault-pfizer-for-non-cooperation-on-its-covid-pill/">Nation Africa &#8211; “Researchers fault Pfizer for non-cooperation on its Covid pill”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://nation.africa/kenya/health/healthy-nation/researchers-fault-pfizer-for-non-cooperation-on-its-covid-pill-3750032" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/nation-africa-researchers-fault-pfizer-for-non-cooperation-on-its-covid-pill/">Nation Africa &#8211; “Researchers fault Pfizer for non-cooperation on its Covid pill”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Politico &#8211; “Research group claims Pfizer is blocking studies on its COVID pill”</title>
		<link>https://anticov.org/in-the-media/2022/politico-research-group-claims-pfizer-is-blocking-studies-on-its-covid-pill/</link>
		
		<dc:creator><![CDATA[Leah Esteves]]></dc:creator>
		<pubDate>Tue, 15 Mar 2022 08:59:00 +0000</pubDate>
				<category><![CDATA[In the media]]></category>
		<guid isPermaLink="false">https://anticov.org/?p=2316</guid>

					<description><![CDATA[<p>Read the article</p>
<p>The post <a href="https://anticov.org/in-the-media/2022/politico-research-group-claims-pfizer-is-blocking-studies-on-its-covid-pill/">Politico &#8211; “Research group claims Pfizer is blocking studies on its COVID pill”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p><a href="https://pro.politico.eu/news/147504" target="_blank" rel="noreferrer noopener">Read the article</a></p>
<p>The post <a href="https://anticov.org/in-the-media/2022/politico-research-group-claims-pfizer-is-blocking-studies-on-its-covid-pill/">Politico &#8211; “Research group claims Pfizer is blocking studies on its COVID pill”</a> appeared first on <a href="https://anticov.org">ANTICOV Trial</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
